TR200001715T2 - Potasyum kanalı açıcıları. - Google Patents

Potasyum kanalı açıcıları.

Info

Publication number
TR200001715T2
TR200001715T2 TR2000/01715T TR200001715T TR200001715T2 TR 200001715 T2 TR200001715 T2 TR 200001715T2 TR 2000/01715 T TR2000/01715 T TR 2000/01715T TR 200001715 T TR200001715 T TR 200001715T TR 200001715 T2 TR200001715 T2 TR 200001715T2
Authority
TR
Turkey
Prior art keywords
potassium channel
channel openers
relates
potassium
opening
Prior art date
Application number
TR2000/01715T
Other languages
English (en)
Inventor
A. Carroll William
W. Holladay Mark
P. Sullivan James
Drizin Irene
Q. Zhang Henry
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/206,055 external-priority patent/US6265417B1/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR200001715T2 publication Critical patent/TR200001715T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Ladders (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Gyroscopes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Weting (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feeding And Controlling Fuel (AREA)

Abstract

Söz konusu bulus Formül I'e sahip olan terkiplerin potasyum kanali açicilari ile engellenebilen ya da tedavisi mümkün olan hastaliklarin tedavisinde kullanimlari ile ilgilidir. Bulus ayrica potasyum kanali açici bilesimler ve bir memelide potasyum kanallarini açma yöntemi ile ilgilidir.
TR2000/01715T 1997-12-18 1998-12-16 Potasyum kanalı açıcıları. TR200001715T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99339297A 1997-12-18 1997-12-18
US09/206,055 US6265417B1 (en) 1997-12-18 1998-12-04 Potassium channel openers

Publications (1)

Publication Number Publication Date
TR200001715T2 true TR200001715T2 (tr) 2000-12-21

Family

ID=26901004

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01715T TR200001715T2 (tr) 1997-12-18 1998-12-16 Potasyum kanalı açıcıları.

Country Status (22)

Country Link
US (1) US20010036950A1 (tr)
EP (1) EP1040097B1 (tr)
JP (1) JP2002508354A (tr)
CN (1) CN1158259C (tr)
AT (1) ATE264303T1 (tr)
AU (1) AU756505B2 (tr)
BG (1) BG64309B1 (tr)
BR (1) BR9813634A (tr)
CA (1) CA2314948A1 (tr)
DE (1) DE69823227T2 (tr)
DK (1) DK1040097T3 (tr)
ES (1) ES2222000T3 (tr)
HK (1) HK1032583A1 (tr)
HU (1) HUP0100112A3 (tr)
IL (1) IL135985A0 (tr)
NO (1) NO317099B1 (tr)
NZ (1) NZ504371A (tr)
PL (1) PL341298A1 (tr)
PT (1) PT1040097E (tr)
SK (1) SK8732000A3 (tr)
TR (1) TR200001715T2 (tr)
WO (1) WO1999031059A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6642222B2 (en) * 1998-10-28 2003-11-04 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6191140B1 (en) 1998-10-28 2001-02-20 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
CA2348165A1 (en) * 1998-10-28 2000-05-04 Abbott Laboratories Dihydropyridine compounds and methods of use
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
WO2002006237A1 (fr) * 2000-07-18 2002-01-24 Yamanouchi Pharmaceutical Co., Ltd. Medicament comprenant un derive de dicyanopyridine
JP2005525350A (ja) * 2002-02-19 2005-08-25 アボット・ラボラトリーズ ４−フルオロ−ベンズアルデヒドのヨウ素化

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4879384A (en) * 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
US5340819A (en) * 1991-10-21 1994-08-23 Imperial Chemical Industries Plc Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4424678A1 (de) * 1994-07-13 1996-01-18 Bayer Ag Dioxo-thiopyrano-pyridin-carbonsäure-derivate

Also Published As

Publication number Publication date
ES2222000T3 (es) 2005-01-16
DE69823227D1 (de) 2004-05-19
PL341298A1 (en) 2001-04-09
AU1830799A (en) 1999-07-05
US20010036950A1 (en) 2001-11-01
HUP0100112A2 (hu) 2001-08-28
CN1282321A (zh) 2001-01-31
NZ504371A (en) 2002-02-01
WO1999031059A1 (en) 1999-06-24
NO20003104L (no) 2000-08-17
BR9813634A (pt) 2000-10-17
NO317099B1 (no) 2004-08-09
DE69823227T2 (de) 2005-03-10
AU756505B2 (en) 2003-01-16
NO20003104D0 (no) 2000-06-16
PT1040097E (pt) 2004-08-31
SK8732000A3 (en) 2000-11-07
DK1040097T3 (da) 2004-08-02
EP1040097B1 (en) 2004-04-14
CN1158259C (zh) 2004-07-21
CA2314948A1 (en) 1999-06-24
BG64309B1 (bg) 2004-09-30
ATE264303T1 (de) 2004-04-15
JP2002508354A (ja) 2002-03-19
HK1032583A1 (en) 2001-07-27
EP1040097A1 (en) 2000-10-04
HUP0100112A3 (en) 2004-05-28
IL135985A0 (en) 2001-05-20
BG104594A (en) 2001-03-30

Similar Documents

Publication Publication Date Title
NO972922D0 (no) Preparater og metoder for å redusere hudirritasjon
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
TR200000059T2 (tr) Piridin türevleri
CY2473B1 (en) New phenanthridines.
FI971756A0 (fi) CD23:een sitoutuvia aineita
DE60019121D1 (de) Kaliumkanäleöffner
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
BR9808221A (pt) Método de tratamento de tumor.
TR200001715T2 (tr) Potasyum kanalı açıcıları.
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
DE69606321D1 (de) Stabilisiertes sonnenschutzmittel
ATE243036T1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
TR200003202T1 (tr) Potasyum kanalı açıcılar olarak faydalı siklopentanon dihidropiridin bileşikleri
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
PT1259510E (pt) Agentes de abertura de canais de potassio de di-hidropirazolona triciclina e di-hidro-isoxazolona triciclina
WO2000024741A3 (en) Dihydropyridine compounds and their use as potassium channel openers
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
AU6629098A (en) Hair treatment compositions containing reducing sulphur species and zinc compound